{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:41:04Z","timestamp":1786117264891,"version":"build-2736575974"},"reference-count":35,"publisher":"Wiley","issue":"8","license":[{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"},{"start":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T00:00:00Z","timestamp":1782086400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["analyticalsciencejournals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Biomedical Chromatography"],"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Temozolomide, a chemotherapy drug used to treat glioblastoma, has high\u2010dose and dose\u2010related side effects, limiting its use. Resveratrol, a natural polyphenol, showed potential in the treatment of glioblastoma. Many studies showed the synergistic activity of resveratrol and temozolomide against glioblastoma, but no analytical method for simultaneous estimation in a biological matrix is available till date. This study aimed to develop and validate a simple, rapid, and sensitive bioanalytical method using HPLC technique for simultaneous estimation of temozolomide and resveratrol in rat plasma and brain for pharmacokinetic study. Isocratic reversed\u2010phase high\u2010performance liquid chromatography (RP\u2010HPLC) method using C18 column was used. Theophylline and caffeine were used as internal standards for Temozolomide and Resveratrol, respectively. The mobile phase methanol: 0.1% glacial acetic acid (30:70) with flow rate 1.0\u2009mL\/min and 310\u2010nm wavelength was used. The LOD for temozolomide and resveratrol in the plasma was 0.96 and 1.29\u2009\u03bcg\/mL, respectively, whereas LOQ was 2.91 and 3.89\u2009\u03bcg\/mL, respectively. The LOD for temozolomide and resveratrol in brain homogenate was 1.01 and 1.24\u2009\u03bcg\/mL, respectively, whereas LOQ was 3.07 and 3.76\u2009\u03bcg\/mL, respectively. This analytical method can be used for simultaneous estimation of temozolomide and resveratrol in biological samples, with higher sensitivity, resulting in more meaningful and appropriate pharmacokinetic analysis.<\/jats:p>","DOI":"10.1002\/bmc.70507","type":"journal-article","created":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T00:56:26Z","timestamp":1782176186000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bioanalytical RP\u2010HPLC Method Development and Validation for Simultaneous Estimation of Temozolomide and Resveratrol: A Pharmacokinetic Analysis in Rat Plasma and Brain"],"prefix":"10.1002","volume":"40","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4320-4439","authenticated-orcid":false,"given":"Saurabh","family":"Mittal","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Education and Research Jamia Hamdard  New Delhi India"},{"name":"Department of Pharmaceutics, Amity Institute of Pharmacy Amity University  Noida India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5308-0655","authenticated-orcid":false,"given":"Javed","family":"Ali","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Education and Research Jamia Hamdard  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1508-6786","authenticated-orcid":false,"given":"Sanjula","family":"Baboota","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, School of Pharmaceutical Education and Research Jamia Hamdard  New Delhi India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,6,22]]},"reference":[{"key":"e_1_2_9_2_1","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2018.01261"},{"key":"e_1_2_9_3_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12935\u2010021\u201002099\u20100"},{"key":"e_1_2_9_4_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0169854"},{"key":"e_1_2_9_5_1","doi-asserted-by":"publisher","DOI":"10.3171\/2016.1.JNS152077"},{"key":"e_1_2_9_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpha.2015.02.005"},{"key":"e_1_2_9_7_1","doi-asserted-by":"publisher","DOI":"10.1188\/16.CJON.S1.2\u20108"},{"key":"e_1_2_9_8_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejpb.2021.08.011"},{"key":"e_1_2_9_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.09.019"},{"key":"e_1_2_9_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/cddis.2013.388"},{"key":"e_1_2_9_11_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10876-021-02209-y"},{"issue":"6","key":"e_1_2_9_12_1","first-page":"1347","article-title":"Validated HPLC Method for Determination of Temozolomide in Human Plasma","volume":"69","author":"Gilant E.","year":"2012","journal-title":"Acta Poloniae Pharmaceutica"},{"key":"e_1_2_9_13_1","doi-asserted-by":"publisher","DOI":"10.5281\/zenodo.17638632"},{"key":"e_1_2_9_14_1","doi-asserted-by":"publisher","DOI":"10.5530\/ijper.54.1.22"},{"key":"e_1_2_9_15_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27144663"},{"key":"e_1_2_9_16_1","doi-asserted-by":"publisher","DOI":"10.1080\/10826076.2018.1511803"},{"key":"e_1_2_9_17_1","doi-asserted-by":"publisher","DOI":"10.1002\/fsn3.855"},{"key":"e_1_2_9_18_1","doi-asserted-by":"publisher","DOI":"10.3892\/or.2015.4346"},{"key":"e_1_2_9_19_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S258584"},{"key":"e_1_2_9_20_1","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c12760"},{"key":"e_1_2_9_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2021.102458"},{"key":"e_1_2_9_22_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612827666210603152056"},{"key":"e_1_2_9_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/jaoacint\/qsac045"},{"key":"e_1_2_9_24_1","doi-asserted-by":"publisher","DOI":"10.2174\/1381612826666200417141600"},{"key":"e_1_2_9_25_1","doi-asserted-by":"publisher","DOI":"10.2174\/1570159X18666200626204005"},{"key":"e_1_2_9_26_1","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27113507"},{"key":"e_1_2_9_27_1","unstructured":"Prithvi C.2019. \u201cMethod Development and Validation of RP\u2010HPLC for the Simultaneous Estimation of Niacin and Trans\u2010Resveratrol in Bulk Drug and Dosage Forms by Using Human Plasma [Masters PSG College of Pharmacy Peelamedu Coimbatore].\u201dhttp:\/\/repository\u2010tnmgrmu.ac.in\/19089\/."},{"key":"e_1_2_9_28_1","unstructured":"Q 2 (R1) Validation of Analytical Procedures: Text and Methodology.2006."},{"key":"e_1_2_9_29_1","doi-asserted-by":"publisher","DOI":"10.1124\/pr.117.014944"},{"key":"e_1_2_9_30_1","doi-asserted-by":"publisher","DOI":"10.7324\/JAPS.2021.120216"},{"key":"e_1_2_9_31_1","doi-asserted-by":"publisher","DOI":"10.4103\/2231\u20104040.97296"},{"key":"e_1_2_9_32_1","doi-asserted-by":"publisher","DOI":"10.20517\/cdr.2020.79"},{"key":"e_1_2_9_33_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21613"},{"key":"e_1_2_9_34_1","doi-asserted-by":"publisher","DOI":"10.1093\/neuonc\/noad038"},{"key":"e_1_2_9_35_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2021.112164"},{"key":"e_1_2_9_36_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2025.117144"}],"container-title":["Biomedical Chromatography"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.70507","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/bmc.70507","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/bmc.70507","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:38:31Z","timestamp":1786023511000},"score":1,"resource":{"primary":{"URL":"https:\/\/analyticalsciencejournals.onlinelibrary.wiley.com\/doi\/10.1002\/bmc.70507"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,22]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1002\/bmc.70507"],"URL":"https:\/\/doi.org\/10.1002\/bmc.70507","archive":["Portico"],"relation":{},"ISSN":["0269-3879","1099-0801"],"issn-type":[{"value":"0269-3879","type":"print"},{"value":"1099-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,22]]},"assertion":[{"value":"2026-01-28","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-05-15","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-22","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e70507"}}